Chief Scientific Officer · MAIA Biotechnology, Inc. · MAIA Biotechnology, Inc. — Stock Options
Side
A
Value
—
Shares
400.0K
Price
—
Executed
Apr 10, 2026
Disclosed
Apr 14, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Apr 10 executedApr 14, 2026 disclosed
MAIA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Gryaznov Sergei filed this Form 4 reporting a grant or award of MAIA on Apr 10, 2026. It became public on Apr 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Gryaznov Sergeicik:0001913228
Issuer
MAIA Biotechnology, Inc.cik:0001878313
Revision history · 0
No field has changed since this record was first ingested.
